CompletedNot applicableNCT04648137

Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls

Studying Arginine vasopressin deficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Basel, Switzerland
Principal Investigator
Mirjam Christ-Crain, Prof. Dr. med.
Endocrinology, Diabetes and Metabolism, University Hospital Basel
Intervention
study intervention: 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)(diagnostic_test)
Enrollment
30 enrolled
Eligibility
18-65 years · All sexes
Timeline
20212022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04648137 on ClinicalTrials.gov

Other trials for Arginine vasopressin deficiency

Additional recruiting or active studies for the same condition.

See all trials for Arginine vasopressin deficiency

← Back to all trials